Reports
Reports
Sale
The global bioreactors market size was approximately USD 7.12 billion in 2023. The market is further projected to grow at a CAGR of 10.7% in the forecast period of 2024-2032, reaching a value of around USD 17.77 billion by 2032.
Bioreactors are devices, systems, or vessels that are able to support an environment that is biologically active, enabling controlled chemical and biological reactions. Various processes, including aerobic and anaerobic, can be conducted in bioreactors, involving biochemically active materials or organisms. Bioreactors are suited for large scale and high-volume productions and reactions, and are commonly used for fermentation processes.
Based on material, the market is divided into glass, stainless steel, and single-use. On the basis of control type, the market is bifurcated into manual and automated. By usage, the bioreactors market segmentation includes lab-scale production, pilot-scale production, and full-scale production.
Based on scale, the market is categorised into 5L-20L, 20L-200L, 200L-1500L, and above 1500L. On the basis of suppliers, the market is classified into OEM and EPCs. The regional markets for bioreactors are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the global bioreactors market, covering their competitive landscape and latest developments like mergers, acquisitions, investments and expansion plans.
Single-use bioreactors account for a significant portion of the bioreactors market share, supported by their lower costs, greater flexibility, and increased efficiency. The vessels for single-use bioreactors are pre-sterilised and already equipped with the required sensors, impellers, and spargers, leading to quick and easy usage.
Single-use bioreactors are often the preferred choice for the biopharmaceutical industry as their pre-sterilised nature aids in preventing any risk of cross contamination which can be time consuming and damage entire product batches. The various layers and components of single-use bioreactors can be customised as per the need of the process, providing greater flexibility and efficiency, which further supports the demand for single-use bioreactors.
At a regional level, North America occupies a sizable share of the global bioreactors market, fuelled by the growing pharmaceuticals and biotechnology sectors in the region. Countries in North America, such as the United States and Canada, are increasingly investing in localised production capacities for various biopharmaceutical products, thereby increasing the demand for bioreactors.
Moreover, extensive research and development activities are also surging the demand for bioreactors to manufacture new drugs and ingredients to treat a variety of new health conditions. Collaborations between key players, academic institutes, and industries are also anticipated to aid the bioreactors market demand in North America over the coming years.
INFORS HT. develops and produces high-tech and advanced solutions for the biotechnology sector, specialising in shaker incubators, bioprocess control software, and bioreactors. Founded in 1965 and currently based in Basel-Landschaft, Switzerland, the company focuses on simplifying the workflows of biotechnology customers through the use of innovative technology.
Solida Biotech GmBH, headquartered in Munich, Germany, engineers, develops, and manufactures bioprocess equipment, providing institutional and industrial clients with new generation fermenters and bioreactors for diagnostics, research, and production. The company offers flexible solutions for fermentation, cell culture, and white, green, and red biotechnologies.
Merck KGaA is among the oldest chemical and pharmaceutical companies in the world, founded in 1668. Currently based in Darmstadt, Germany, the company holds expertise in life sciences, healthcare, and electronics, with a key focus on research and development to develop innovative products.
Other market players include Bailun Biotech (Jiangsu) Co., LTD, Kuhner AG, Sartorius AG, Thermo Fisher Scientific Inc., Cytiva, PBS Biotech, Inc., and Getinge AB, among others.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Material |
|
Breakup by Control Type |
|
Breakup by Usage |
|
Breakup by Scale |
|
Breakup by Suppliers |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Market Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global Bioreactors Market Analysis
8.1 Key Industry Highlights
8.2 Global Bioreactors Historical Market (2017-2023)
8.3 Global Bioreactors Market Forecast (2024-2032)
8.4 Global Bioreactors Market by Material
8.4.1 Glass
8.4.1.1 Historical Trend (2017-2023)
8.4.1.2 Forecast Trend (2024-2032)
8.4.2 Stainless Steel
8.4.2.1 Historical Trend (2017-2023)
8.4.2.2 Forecast Trend (2024-2032)
8.4.3 Single-Use
8.4.3.1 Historical Trend (2017-2023)
8.4.3.2 Forecast Trend (2024-2032)
8.5 Global Bioreactors Market by Control Type
8.5.1 Manual
8.5.1.1 Historical Trend (2017-2023)
8.5.1.2 Forecast Trend (2024-2032)
8.5.2 Automated
8.5.2.1 Historical Trend (2017-2023)
8.5.2.2 Forecast Trend (2024-2032)
8.6 Global Bioreactors Market by Usage
8.6.1 Lab-Scale Production
8.6.1.1 Historical Trend (2017-2023)
8.6.1.2 Forecast Trend (2024-2032)
8.6.2 Pilot-Scale Production
8.6.2.1 Historical Trend (2017-2023)
8.6.2.2 Forecast Trend (2024-2032)
8.6.3 Full-Scale Production
8.6.3.1 Historical Trend (2017-2023)
8.6.3.2 Forecast Trend (2024-2032)
8.7 Global Bioreactors Market by Scale
8.7.1 5L-20L
8.7.1.1 Historical Trend (2017-2023)
8.7.1.2 Forecast Trend (2024-2032)
8.7.2 20L-200L
8.7.2.1 Historical Trend (2017-2023)
8.7.2.2 Forecast Trend (2024-2032)
8.7.3 200L-1500L
8.7.3.1 Historical Trend (2017-2023)
8.7.3.2 Forecast Trend (2024-2032)
8.7.4 Above 1500L
8.7.4.1 Historical Trend (2017-2023)
8.7.4.2 Forecast Trend (2024-2032)
8.8 Global Bioreactors Market by Suppliers
8.8.1 OEM
8.8.1.1 Historical Trend (2017-2023)
8.8.1.2 Forecast Trend (2024-2032)
8.8.2 EPCs
8.8.2.1 Historical Trend (2017-2023)
8.8.2.2 Forecast Trend (2024-2032)
8.9 Global Bioreactors Market by Region
8.9.1 North America
8.9.1.1 Historical Trend (2017-2023)
8.9.1.2 Forecast Trend (2024-2032)
8.9.2 Europe
8.9.2.1 Historical Trend (2017-2023)
8.9.2.2 Forecast Trend (2024-2032)
8.9.3 Asia Pacific
8.9.3.1 Historical Trend (2017-2023)
8.9.3.2 Forecast Trend (2024-2032)
8.9.4 Latin America
8.9.4.1 Historical Trend (2017-2023)
8.9.4.2 Forecast Trend (2024-2032)
8.9.5 Middle East and Africa
8.9.5.1 Historical Trend (2017-2023)
8.9.5.2 Forecast Trend (2024-2032)
9 North America Bioreactors Market Analysis
9.1 United States of America
9.1.1 Historical Trend (2017-2023)
9.1.2 Forecast Trend (2024-2032)
9.2 Canada
9.2.1 Historical Trend (2017-2023)
9.2.2 Forecast Trend (2024-2032)
10 Europe Bioreactors Market Analysis
10.1 United Kingdom
10.1.1 Historical Trend (2017-2023)
10.1.2 Forecast Trend (2024-2032)
10.2 Germany
10.2.1 Historical Trend (2017-2023)
10.2.2 Forecast Trend (2024-2032)
10.3 France
10.3.1 Historical Trend (2017-2023)
10.3.2 Forecast Trend (2024-2032)
10.4 Italy
10.4.1 Historical Trend (2017-2023)
10.4.2 Forecast Trend (2024-2032)
10.5 Others
11 Asia Pacific Bioreactors Market Analysis
11.1 China
11.1.1 Historical Trend (2017-2023)
11.1.2 Forecast Trend (2024-2032)
11.2 Japan
11.2.1 Historical Trend (2017-2023)
11.2.2 Forecast Trend (2024-2032)
11.3 India
11.3.1 Historical Trend (2017-2023)
11.3.2 Forecast Trend (2024-2032)
11.4 ASEAN
11.4.1 Historical Trend (2017-2023)
11.4.2 Forecast Trend (2024-2032)
11.5 Australia
11.5.1 Historical Trend (2017-2023)
11.5.2 Forecast Trend (2024-2032)
11.6 Others
12 Latin America Bioreactors Market Analysis
12.1 Brazil
12.1.1 Historical Trend (2017-2023)
12.1.2 Forecast Trend (2024-2032)
12.2 Argentina
12.2.1 Historical Trend (2017-2023)
12.2.2 Forecast Trend (2024-2032)
12.3 Mexico
12.3.1 Historical Trend (2017-2023)
12.3.2 Forecast Trend (2024-2032)
12.4 Others
13 Middle East and Africa Bioreactors Market Analysis
13.1 Saudi Arabia
13.1.1 Historical Trend (2017-2023)
13.1.2 Forecast Trend (2024-2032)
13.2 United Arab Emirates
13.2.1 Historical Trend (2017-2023)
13.2.2 Forecast Trend (2024-2032)
13.3 Nigeria
13.3.1 Historical Trend (2017-2023)
13.3.2 Forecast Trend (2024-2032)
13.4 South Africa
13.4.1 Historical Trend (2017-2023)
13.4.2 Forecast Trend (2024-2032)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Competitive Landscape
15.1 Market Structure
15.2 Company Profiles
15.2.1 INFORS HT.
15.2.1.1 Company Overview
15.2.1.2 Product Portfolio
15.2.1.3 Demographic Reach and Achievements
15.2.1.4 Certifications
15.2.2 Solida Biotech GmBH
15.2.2.1 Company Overview
15.2.2.2 Product Portfolio
15.2.2.3 Demographic Reach and Achievements
15.2.2.4 Certifications
15.2.3 Bailun Biotech (Jiangsu) Co., LTD
15.2.3.1 Company Overview
15.2.3.2 Product Portfolio
15.2.3.3 Demographic Reach and Achievements
15.2.3.4 Certifications
15.2.4 Merck KGaA
15.2.4.1 Company Overview
15.2.4.2 Product Portfolio
15.2.4.3 Demographic Reach and Achievements
15.2.4.4 Certifications
15.2.5 Kuhner AG
15.2.5.1 Company Overview
15.2.5.2 Product Portfolio
15.2.5.3 Demographic Reach and Achievements
15.2.5.4 Certifications
15.2.6 Sartorius AG
15.2.6.1 Company Overview
15.2.6.2 Product Portfolio
15.2.6.3 Demographic Reach and Achievements
15.2.6.4 Certifications
15.2.7 Thermo Fisher Scientific Inc.
15.2.7.1 Company Overview
15.2.7.2 Product Portfolio
15.2.7.3 Demographic Reach and Achievements
15.2.7.4 Certifications
15.2.8 Cytiva
15.2.8.1 Company Overview
15.2.8.2 Product Portfolio
15.2.8.3 Demographic Reach and Achievements
15.2.8.4 Certifications
15.2.9 PBS Biotech, Inc.
15.2.9.1 Company Overview
15.2.9.2 Product Portfolio
15.2.9.3 Demographic Reach and Achievements
15.2.9.4 Certifications
15.2.10 Getinge AB
15.2.10.1 Company Overview
15.2.10.2 Product Portfolio
15.2.10.3 Demographic Reach and Achievements
15.2.10.4 Certifications
15.2.11 Others
16 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Global Bioreactors Market: Key Industry Highlights, 2017 and 2032
2. Global Bioreactors Historical Market: Breakup by Material (USD Billion), 2017-2023
3. Global Bioreactors Market Forecast: Breakup by Material (USD Billion), 2024-2032
4. Global Bioreactors Historical Market: Breakup by Control Type (USD Billion), 2017-2023
5. Global Bioreactors Market Forecast: Breakup by Control Type (USD Billion), 2024-2032
6. Global Bioreactors Historical Market: Breakup by Usage (USD Billion), 2017-2023
7. Global Bioreactors Market Forecast: Breakup by Usage (USD Billion), 2024-2032
8. Global Bioreactors Historical Market: Breakup by Scale (USD Billion), 2017-2023
9. Global Bioreactors Market Forecast: Breakup by scale (USD Billion), 2024-2032
10. Global Bioreactors Historical Market: Breakup by supplier (USD Billion), 2017-2023
11. Global Bioreactors Market Forecast: Breakup by Supplier (USD Billion), 2024-2032
12. Global Bioreactors Historical Market: Breakup by End User (USD Billion), 2017-2023
13. Global Bioreactors Market Forecast: Breakup by End User (USD Billion), 2024-2032
14. Global Bioreactors Historical Market: Breakup by Region (USD Billion), 2017-2023
15. Global Bioreactors Market Forecast: Breakup by Region (USD Billion), 2024-2032
16. North America Bioreactors Historical Market: Breakup by Country (USD Billion), 2017-2023
17. North America Bioreactors Market Forecast: Breakup by Country (USD Billion), 2024-2032
18. Europe Bioreactors Historical Market: Breakup by Country (USD Billion), 2017-2023
19. Europe Bioreactors Market Forecast: Breakup by Country (USD Billion), 2024-2032
20. Asia Pacific Bioreactors Historical Market: Breakup by Country (USD Billion), 2017-2023
21. Asia Pacific Bioreactors Market Forecast: Breakup by Country (USD Billion), 2024-2032
22. Latin America Bioreactors Historical Market: Breakup by Country (USD Billion), 2017-2023
23. Latin America Bioreactors Market Forecast: Breakup by Country (USD Billion), 2024-2032
24. Middle East and Africa Bioreactors Historical Market: Breakup by Country (USD Billion), 2017-2023
25. Middle East and Africa Bioreactors Market Forecast: Breakup by Country (USD Billion), 2024-2032
26. Global Bioreactors Market Structure
In 2023, the market reached an approximate value of USD 7.12 billion.
The market is projected to grow at a CAGR of 10.7% between 2024 and 2032.
The market is estimated to witness a healthy growth in the forecast period of 2024-2032, reaching a value of around USD 17.77 billion by 2032.
The major drivers of the market include rising demand in pharmaceuticals, increasing research and development activities, and growing demand for single-use and hybrid bioreactors.
The key bioreactors market trends include advancements in bioreactors, increasing investments in pharmaceutical manufacturing, and increasing use in green biotechnology.
The significant control types in the market for bioreactors are manual and automated.
The various usages of bioreactors in the market are lab-scale production, pilot-scale production, and full-scale production.
The major players in the market are INFORS HT., Solida Biotech GmBH, Bailun Biotech (Jiangsu) Co., LTD, Merck KGaA, Kuhner AG, Sartorius AG, Thermo Fisher Scientific Inc., Cytiva, PBS Biotech, Inc., and Getinge AB, among others.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.